Equivalent price position
No other current listing with the same generic, strength, dosage form and compatible unit basis is available for comparison.
Price-position comparison uses current official listed prices normalized to compatible units. It is a price benchmark, not a measure of sales, demand, prescription volume or market share.
Product details
- Generic
- Sodium valproate
- Therapeutic area
- CNS & mental health
- Drug class
- Antiepileptics
- ATC
- N03
- Strength
- 250 MG /5 mL
- Dosage form
- Syrup
- Pack
- 300ml
- Registration no.
- 024466
- Price record verified
- 2026-08-11
- Latest DRAP source check
- 2026-09-23 03:19
Manufacturer
Explore this manufacturer's complete MedInfoBase portfolio, generics and current listed prices.
View company portfolio →Official price over time
PKR 487.91 to 539.11 (+10.5%) between 1 Jul 2024 and 23 Jul 2026 · 2 official price records · pack 300ml
Step chart: a notified price holds until DRAP notifies the next one. Hover or tap a point for its date and change.
Cite this price history
MedInfoBase. DAPAKAN 250 MG /5 mL, 300ml: official price history (source: DRAP PharmaPrice Index). https://medinfobase.com/brand/dapakan-250-mg-5-ml-024466-120ml-platinum-pharmaceuticals/ (accessed 24 September 2026).
Official price history
| Amount | Effective from | Verified | Source | Status |
|---|---|---|---|---|
| PKR 539.11 | 2026-07-23 | 2026-08-11 | DRAP PharmaPrice Index | Current |
| PKR 487.91 | 2024-07-01 | 2026-08-11 | DRAP PharmaPrice Index | Historical |
Other listed brands
Cite this record
Medicine record · DRAP registration 024466Price and registration data on this page were observed on 11 August 2026. Records change over time, so please cite the observation date alongside the access date.
